Many investors, including Carl Icahn or Stan Druckenmiller, have been saying for a while now that the current market is overvalued due to a low interest rate environment that leads to companies swapping their equity for debt and focusing mostly on short-term performance such as beating the quarterly earnings estimates. In the third quarter, many investors lost money due to unpredictable events such as the concerns over Valeant’s drug pricing policy that led to an overall drop among pharma stocks. Nevertheless, many of the stocks that tanked in the third quarter still sport strong fundamentals and their decline was more related to the general market sentiment rather than their individual performance and hedge funds kept their bullish stance. In this article we will find out how hedge fund sentiment to Innophos Holdings, Inc. (NASDAQ:IPHS) changed recently.
Is Innophos Holdings, Inc. (NASDAQ:IPHS) a good stock to buy now? Prominent investors are buying. The number of long hedge fund positions went up by 8 lately. Innophos Holdings, Inc. (NASDAQ:IPHS) was in 22 hedge funds’ portfolios at the end of September. There were 14 hedge funds in our database with Innophos Holdings, Inc. (NASDAQ:IPHS) positions at the end of the previous quarter. At the end of this article, we will also compare Innophos Holdings, Inc. (NASDAQ:IPHS) to other stocks, including Saia Inc (NASDAQ:SAIA), Atento SA (NYSE:ATTO), and HMS Holdings Corp. (NASDAQ:HMSY) to get a better sense of its popularity.
In the financial world, there are plenty of metrics stock market investors have at their disposal to analyze publicly traded companies. Some of the most useful metrics are hedge fund and insider trading indicators. Our experts have shown that, historically, those who follow the top picks of the best hedge fund managers can beat the broader indices by a very impressive margin (see the details here).
Now, let’s take a glance at the latest action encompassing Innophos Holdings, Inc. (NASDAQ:IPHS).
What does the smart money think about Innophos Holdings, Inc. (NASDAQ:IPHS)?
At the end of September, a total of 22 of the hedge funds tracked by Insider Monkey were long this stock, an increase of 57% from the second quarter. With hedgies’ capital changing hands, there exists an “upper tier” of noteworthy hedge fund managers who were increasing their holdings considerably (or already accumulated large positions).
When looking at the institutional investors followed by Insider Monkey, Renaissance Technologies holds the most valuable position in Innophos Holdings, Inc. (NASDAQ:IPHS). Renaissance Technologies has a $16.6 million position in the stock, comprising less than 0.1% of its 13F portfolio. Sitting at the No. 2 spot is Lee Munder Capital Group, managed by Lee Munder, which holds a $11.9 million position; the fund has 0.3% of its 13F portfolio invested in the stock. Other professional money managers with similar optimism contain Stephen Loukas, David A. Lorber, Zachary George’s FrontFour Capital Group, Jay Petschek and Steven Major’s Corsair Capital Management and D E Shaw.